Excessive hypertension and end-organ damage in a transgenic mouse line carrying the rat angiotensinogen gene

Journal of Cardiovascular Pharmacology

Volumn 53, Issue 1, 2009, Pages 38-43

  Xu, Ping ^a,d   Wang, Yong ^a,b   Sterner Kock, Anja ^c   Bader, Michael ^d   Schultheiss, Heinz Peter ^a   Walther, Thomas ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF HULL   (United Kingdom)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

^d MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Angiotensinogen; Cardiac hypertrophy; Fibrosis; Hypertension; Transgenic mice

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSINOGEN; BRAIN NATRIURETIC PEPTIDE; COLLAGEN TYPE 3; ANTIHYPERTENSIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CHRONIC DISEASE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HEART; HEART FAILURE; HEART FUNCTION; HEART HYPERTROPHY; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HEMODYNAMICS; HYPERTENSION; KIDNEY; LUNG; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE DISTRIBUTION; TRANSGENIC MOUSE; ANIMAL; BLOOD; CARDIOMEGALY; DRUG EFFECTS; FIBROSIS; GENE; GENETICS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TRANSGENIC RAT;

ANGIOTENSINOGEN; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CARDIOMEGALY; FIBROSIS; GENES; HEART; HYPERTENSION; KIDNEY; MALE; MICE; MICE, TRANSGENIC; RATS; RATS, TRANSGENIC; RENIN-ANGIOTENSIN SYSTEM;

EID: 67651095735     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e3181953e44     Document Type: Article

References (21)

1. Davisson RL, Yang G, Beltz TG, et al. The brain renin-angiotensin system contributes to the hypertension in mice containing both the human renin and human angiotensinogen transgenes. Circ Res. 1998;83:1047-1058. (Pubitemid 28520934)
2. Tschope C, Walther T, Yu M, et al. Myocardial expression of rat bradykinin receptors and two tissue kallikrein genes in experimental diabetes. Immunopharmacology. 1999;44(1-2):35-42.
3. Morgan L, Broughton Pipkin F, Kalsheker N. Angiotensinogen: molecular biology, biochemistry and physiology. Int J Biochem Cell Biol. 1996;28: 1211-1222. (Pubitemid 27033137)
4. Kimura S, Mullins JJ, Bunnemann B, et al. High blood pressure in transgenic mice carrying the rat angiotensinogen gene. EMBO J. 1992;11: 821-827.
5. Oliver WJ, Gross F. Unique specificity of mouse angiotensinogen to homologous renin. Proc Soc Exp Biol Med. 1966;122:923-926.
6. Walther T, Balschun D, Voigt JP, et al. Sustained long term potentiation and anxiety in mice lacking the Mas protooncogene. J Biol Chem. 1998; 273:11867-11873. (Pubitemid 28272093)
7. Wang Y, de Waard MC, Sterner-Kock A, et al. Cardiomyocyte-restricted over-expression of C-type natriuretic peptide prevents cardiac hypertrophy induced by myocardial infarction in mice. Eur J Heart Fail. 2007;9: 548-557. (Pubitemid 46702821)
8. Walther T, Klostermann K, Heringer-Walther S, et al. Fibrosis rather than blood pressure determines cardiac BNP expression in mice. Regul Pept. 2003;116(1-3):95-100. (Pubitemid 37352920)
9. Walther T, Tschope C, Sterner-Kock A, et al. Accelerated mitochondrial adenosine diphosphate/adenosine triphosphate transport improves hypertension-induced heart disease. Circulation. 2007;115:333-344. (Pubitemid 46148508)
10. Dostal DE, Rothblum KN, Baker KM. An improved method for absolute quantification of mRNA using multiplex polymerase chain reaction: determination of renin and angiotensinogen mRNA levels in various tissues. Anal Biochem. 1994;223:239-250.
11. Merrill DC, Thompson MW, Carney CL, et al. Chronic hypertension and altered baroreflex responses in transgenic mice containing the human renin and human angiotensinogen genes. J Clin Invest. 1996;97: 1047-1055.
12. Yang G, Merrill DC, Thompson MW, et al. Functional expression of the human angiotensinogen gene in transgenic mice. J Biol Chem. 1994;269: 32497-32502.
13. Mullins JJ, Peters J, Ganten D. Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature. 1990;344:541-544. (Pubitemid 20124430)
14. Bohlender J, Fukamizu A, Lippoldt A, et al. High human renin hypertension in transgenic rats. Hypertension. 1997;29(Pt 2):428-434. (Pubitemid 27074079)
15. Fukamizu A, Sugimura K, Takimoto E, et al. Chimeric renin-angiotensin system demonstrates sustained increase in blood pressure of transgenic mice carrying both human renin and human angiotensinogen genes. J Biol Chem. 1993;268:11617-11621. (Pubitemid 23168109)
16. Bohlender J, Menard J, Wagner J, et al. Human renin-dependent hypertension in rats transgenic for human angiotensinogen. Hypertension. 1996;27(Pt 2):535-540. (Pubitemid 26084621)
17. Ganten D, Wagner J, Zeh K, et al. Species specificity of renin kinetics in transgenic rats harboring the human renin and angiotensinogen genes. Proc Natl Acad Sci U S A. 1992;89:7806-7810.
18. Hatae T, Takimoto E, Murakami K, et al. Comparative studies on speciesspecific reactivity between renin and angiotensinogen. Mol Cell Biochem. 1994;131:43-47. (Pubitemid 24139174)
19. Reudelhuber TL, Bernstein KE, Delafontaine P. Is angiotensin II a direct mediator of left ventricular hypertrophy? Time for another look. Hypertension. 2007;49:1196-1201. (Pubitemid 46809352)
20. Kang N, Walther T, Tian XL, et al. Reduced hypertension-induced endorgan damage in mice lacking cardiac and renal angiotensinogen synthesis. J Mol Med. 2002;80:359-366. (Pubitemid 34775374)
21. Brilla CG, Zhou G, Matsubara L, et al. Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone. J Mol Cell Cardiol. 1994;26:809-820. (Pubitemid 24223231)